Could a vaccine for COVID-19 be developed right here in the Lehigh Valley? It’s possible thanks to an early-stage pharmaceutical company, which last year purchased a building on Allentown’s south side after outgrowing its existing production facility in Bethlehem. US Specialty Formulations LLC is a contract CGMP manufacturer and one of the first 503B Drug Quality and Security Act outsourcing facilities registered with the U.S. Food & Drug Administration.
It cost-effectively produces specialty formulations of pharmaceuticals in small batches for larger pharmaceutical and healthcare organizations.
USSF focuses on two lines of business: specialty products, such as topicals and sterile injectables for both humans and animals; and investigational drugs for clinical trials. USSF is partnering with fellow Ben Franklin Technology Partners TechVentures resident company VaxForm, LLC, which is owned by USSF co-founder Dr. Garry Morefield, on the development of a COVID-19 vaccine.
Pre-clinical trials will start soon,” said Dr. Kyle Flanigan, Co-Founder and CEO of USSF. “If the vaccine is approved, we will need to ramp up production very quickly, producing between 500,000 and 600,000 doses per month. We also have the ability to provide a manufacturing facility for the rapid turnaround for first responder pharmaceuticals.
Read More